Zoll Medical Corp.
Division of Asahi Kasei Corp.
www.zoll.com
Latest From Zoll Medical Corp.
Zoll Zeroes In On TherOx, Acquires SSO2 Therapy
Just months after receiving USA FDA approval for its SuperSaturated Oxygen (SSO2) Therapy for heart-attack treatment, Californian company TherOx has been acquired by Zoll Medical for an undisclosed sum.
FDA Approves TherOx’s SuperSaturated Oxygen Heart Attack Therapy
Clinical trials have shown that SuperSaturated Oxygen Therapy (SSO2 Therapy) reduces the size of myocardial infarcts in the regions of the heart-muscle perfused by the patient’s left anterior descending coronary artery immediately following stenting.
Mixed Results Of Zoll's LifeVest Trial Sparks Reaction From Cardiologists
Results of VEST, the first randomized, multi-center trial of Zoll's LifeVest wearable cardioverter defibrillator for prevention of sudden cardiac death following a heart attack, missed its primary endpoint, a reduction in sudden cardiac deaths. However, patients randomized to LifeVest had lower overall risk of mortality than the patients randomized to standard medical therapy. The conflicting results triggered a lot of discussion among cardiologists online.
Court Revives Zoll Product Safety Suit Following Earlier Premption Ruling
The Eleventh Circuit Court of Appeals reversed a lower court's decision that US FDA regulations pre-empted a product liability suit against Zoll Medical. The suit was filed by the son of a woman who allegedly died after her Zoll LifeVest external defibrillator malfunctioned.
Company Information
- Industry
-
Medical Devices
- Infusion Therapy Equipment and Supplies
- Monitoring Equipment & Devices
- Therapeutic Areas
- Cardiovascular
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Asahi Kasei Corp.
- Senior Management
-
Jonathan A Rennert, CEO
Eric L Knudsen, VP, Bus. Dev.
Steven K Flora, SVP, VP, North American Sales - Contact Info
-
Zoll Medical Corp.
Phone: (978) 421-9655
269 Mill Rd.
Chelmsford, MA 01824-4105
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice